**Core Concept**
Bromocriptine is a dopamine agonist that inhibits prolactin secretion from the pituitary gland. It is used to treat hyperprolactinemia, a condition characterized by elevated levels of prolactin in the blood, which can disrupt the normal hypothalamic-pituitary-ovarian axis and lead to infertility in women.

**Why the Correct Answer is Right**
The primary mechanism of bromocriptine is the stimulation of dopamine receptors in the pituitary gland, specifically the D2 receptors, which inhibits the release of prolactin. Elevated prolactin levels can suppress gonadotropin-releasing hormone (GnRH) secretion, leading to decreased follicle-stimulating hormone (FSH) and luteinizing hormone (LH) production, resulting in amenorrhea and infertility. Bromocriptine's ability to decrease prolactin levels restores the normal balance of gonadotropins, allowing for ovulation and fertility.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because bromocriptine is not primarily used to treat polycystic ovary syndrome (PCOS), although it may be used as an adjunct therapy in some cases. PCOS is a complex endocrine disorder characterized by insulin resistance, hyperandrogenism, and ovulatory dysfunction.

**Option B:** This option is incorrect because bromocriptine is not used to treat premature ovarian failure (POF), also known as premature menopause. POF is a condition characterized by the cessation of ovarian function before the age of 40, resulting in amenorrhea and infertility.

**Option C:** This option is incorrect because bromocriptine is not used to treat thyroid dysfunction, such as hypothyroidism or hyperthyroidism. Bromocriptine's primary indication is the treatment of hyperprolactinemia, not thyroid disorders.

**Option D:** This option is incorrect because bromocriptine is not used to treat adrenal insufficiency, a condition characterized by the inadequate production of cortisol and/or aldosterone. Bromocriptine's primary indication is the treatment of hyperprolactinemia, not adrenal disorders.

**Clinical Pearl / High-Yield Fact**
Bromocriptine's efficacy in treating hyperprolactinemia is often evaluated by measuring the patient's prolactin levels before and after treatment. A decrease in prolactin levels typically indicates a positive response to therapy.

**Correct Answer:** C. Hyperprolactinemia.